VEGFA and hypertensive disorder: To test the hypothesis that recombinant VEGF therapy will attenuate the hypertension in the RUPP model, rhVEGF121 therapy was administered via osmotic mini pump on gestational day 14 when the RUPP and sham surgeries were performed.